GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (XPAR:EAPI) » Definitions » Accounts Payable

Euroapi (XPAR:EAPI) Accounts Payable : €104.9 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Accounts Payable?

Euroapi's Accounts Payable for the quarter that ended in Dec. 2024 was €104.9 Mil.

Euroapi's quarterly Accounts Payable declined from Dec. 2023 (€159.6 Mil) to Jun. 2024 (€143.6 Mil) and declined from Jun. 2024 (€143.6 Mil) to Dec. 2024 (€104.9 Mil).

Euroapi's annual Accounts Payable declined from Dec. 2022 (€219.6 Mil) to Dec. 2023 (€159.6 Mil) and declined from Dec. 2023 (€159.6 Mil) to Dec. 2024 (€104.9 Mil).


Euroapi Accounts Payable Historical Data

The historical data trend for Euroapi's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Accounts Payable Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial 131.10 189.60 219.60 159.60 104.90

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only 219.60 164.80 159.60 143.60 104.90

Euroapi Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Euroapi Accounts Payable Related Terms

Thank you for viewing the detailed overview of Euroapi's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroapi Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.

Euroapi Headlines

No Headlines